Zdrowie i gospodarka · 13/03/2008

FDA Releases Draft Guidance on Hypertension Drug Labeling for Cardiovascular Outcomes

The US Food and Drug Administration (FDA) has published a draft guidance to help pharmaceutical companies develop labels for medications used to treat high blood pressure, highlighting the benefits of lower blood pressure in reducing cardiovascular risks.